as on February 3, 2026 at 2:29 am IST
Day's Low
Day's High
3.06%
Downside
2.41%
Upside
52 Week's Low
52 Week's High
60.07%
Downside
28.88%
Upside
Check Apogee Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$4.8B
EPS (TTM)
-4.206
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-282.3M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-38.41%
Compare market cap, revenue, PE, and other key metrics of Apogee Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $4.8B | NA | NA | 0.00% |
The Apogee Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Apogee Therapeutics investment value today
Current value as on today
₹1,67,714
Returns
₹67,714
(+67.71%)
Returns from Apogee Therapeutics Stock
₹62,522 (+62.52%)
Dollar Returns*
₹5,193 (+5.19%)
Based on 12 analysts
91.67%
Buy
8.33%
Hold
0.00%
Sell
Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Apogee Therapeutics. Average target price of $104.5
Get share price movements and forecasts by analysts on Apogee Therapeutics.
What analysts predicted
37.22%UPSIDE
Target Price
$104.5
Current Price
$65.61
Analyzed by
12 Analysts
Target
$104.50
Apogee Therapeutics target price $104.5, a slight upside of 37.22% compared to current price of $65.61. According to 12 analysts rating.
Search interest for Apogee Therapeutics Stock has increased by 180% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:180% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
| Organisation | Apogee Therapeutics |
| Headquarters | Building 17, Waltham, MA, United States, 02453 |
| CEO | Dr. Michael Thomas Henderson M.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Ms. Jane Pritchett V. Henderson | Chief Financial Officer |
Ms. Noel Kurdi | Vice President of Investor Relations |
Mr. Matthew Batters J.D. | Chief Legal Officer & Corporate Secretary |
Ms. Wendy Aspden-Curran | Senior Vice President of Clinical Operations |
Ms. Monica Forbes | Senior Vice President of Finance |
Dr. Michael Thomas Henderson M.D. | CEO & Director |
Dr. Carl Linden Dambkowski M.D. | Chief Medical Officer |
Ms. Emily Cox | SVP & Head of People |
Dr. Rebecca Dabora Ph.D. | Chief Development Officer |
Dr. Drew Badger Ph.D. | Senior VP and Head of Regulatory Affairs & Toxicology |
Apogee Therapeutics share price today is $65.61 as on at the close of the market. Apogee Therapeutics share today touched a day high of $67.19 and a low of $63.6.
Apogee Therapeutics share touched a 52 week high of $84.56 on and a 52 week low of $26.2 on . Apogee Therapeutics stock price today i.e. is closed at $65.61,which is 22.41% down from its 52 week high and 150.42% up from its 52 week low.
Apogee Therapeutics market capitalisation is $0.00T as on .
Indian investors can start investing in Apogee Therapeutics (APGE) shares with as little as ₹91.486 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹914.86 in Apogee Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Apogee Therapeutics share’s latest price of $65.61 as on February 3, 2026 at 2:29 am IST, you will get 0.1524 shares of Apogee Therapeutics. Learn more about
fractional shares .